Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

19 Nov 2009 07:00

RNS Number : 7197C
Tarsus Group PLC
19 November 2009
 



19 November 2009

TARSUS GROUP plc

Interim Management Statement

Tarsus Group plc ('Tarsus' or 'the Group'), the international media group with interests in exhibitions, conferences, publishing and online media, is today publishing its Interim Management Statement relating to the period from the publication of its interim results on 29 July 2009 to 18 November 2009. 

Trading Performance

Trading for the period has been in line with the Board's expectations. A summary of the more significant developments during the period includes:

Emerging Markets

The Dubai Airshow, the Group's largest event which finishes todayhas been a major success with revenues materially ahead of the previous edition despite well published issues affecting the global civil aviation industry and a difficult economic climate in Dubai

The Dubai Airshow is the fastest growing event of the larger airshows. Attendance has been excellent with a number of large aircraft orders announced during the event.

The Dubai Airshow was acquired in November 2007 as part of the acquisition of Fairs & Exhibitions (F&E). Following the completion of the earn-out period at the end of JuneTarsus has been integrating the business into the rest of the Group. The process is well advanced and will be substantially complete by the year end. The integration will result in a small exceptional charge.

Tarsus's Chinese business has continued to be developed both organically and through small bolt-on acquisitions. Revenues have grown approximately 15% in the year-to-date driven by 6 new launches and 3 small acquisitions.

Europe

Labelexpo Europe in September, the Group's second largest event, produced like-for-like revenue growth of 14%.

The event was one of the most successful in its 30 year history with exhibitor expectations being exceeded in terms of attendance and buying interest. Re-bookings have also exceeded internal expectations with an 80% rebook rate, thereby providing Tarsus with a high level of visibility for the 2011 event.

Our French portfolio and other small products in Europe continued to find the economic environment difficult. The French business has performed broadly in line with our reduced expectations at the interim stage with year-to-date revenues declining 12% compared with 2008. Whilst there are early signs of economic stabilisation, the Group continues to adopt a cautious stance for 2010.

US

The August 2009 Off-Price Show in Las Vegas performed well. Sales improved strongly from the February show and were slightly up compared with the previous August edition. Encouragingly, as with Labelexpo Europe, forward visibility for this event is strong with re-bookings for the next event in February 2010 at a record level

The Medical Division held a number of events during the period the largest of which was in San Jose in September. The revenue streams from within this division have continued to be reconfigured towards education and training resulting in slightly lower turnover and improved margins.

Financial Position

The Group has continued with its strategy of tight cost control and prudent financial management. Net debt has continued to reduce during the period from £34.8million at 30 June 2009 to £32.6m at 16 November 2009

Outlook 

The Group's large events have continued to perform extremely well with smaller products, in line with the rest of the industry, being impacted by difficult market conditions. Overall, attendances at our events are ahead of previous editions reflecting the strength of Tarsus' portfolio. We are confident of satisfactory outcome for 2009 at current exchange rates.

Tarsus Group plc

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

Media

Madano Partnership 

Matthew Moth 020 7593 4000

Investors/Analysts

IRfocus

Neville Harris 020 7593 4015

Scott Harris

Stephen Scott, Jeremy Wiseman 020 7653 0030

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSCKFKNPBDDQDD
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBoard Changes
9th May 20187:00 amRNSBlock Listing Six Monthly Return
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.